The Efficacy of Denosumab in Active Crohn's Disease

NCT02321280 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Denosumab

Sponsor

University of Manitoba

Collaborators

[object Object]
[object Object]